|

Tislelizumab Injection Clinical Trials

3 actively recruiting trials

Also known as: Tislelizumab

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • Nanjing Leads Biolabs Co.,Ltd2
  • Ji Yongling1

Indications

  • Cancer3
  • Advanced Solid Tumour1
  • Malignant Tumors1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Other3 trials

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
Phase 2
A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
Phase 1/2
Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.